Medium- to Long-Term Incentives Through Performance-Conditioned Stock Acquisition Rights
First written in FY2019-Q1. 4 of 8 entries say "Advanced", first in FY2019-Q2. Latest entry: FY2023.
- FY2023DroppedAnnual report
「3. These stock acquisition rights have lapsed because the vesting conditions were not met.」
The performance-conditioned stock acquisition rights from the 5th through 12th Series lapsed because the vesting conditions were not met. The previous medium- to long-term incentive program ended following this determination of the conditions. - FY2021AdvancedAnnual report
「11th Series Stock Acquisition Rights: Common shares, 242,000; 12th Series Stock Acquisition Rights: Common shares, 158,000; Exercise period for stock acquisition rights: 1 July 2023 to 30 June 2024」
The 11th and 12th Series Stock Acquisition Rights were granted on 31 March 2021, adding a medium- to long-term incentive covering a total of 400,000 shares. The exercise period and performance conditions, including ordinary profit exceeding ¥12.5 billion for the fiscal year ending March 2023, are unchanged from the previous terms. - FY2021-Q2AdvancedAnnual report
「During the second quarter of the current consolidated fiscal period, the Company issued stock acquisition rights. “Number of stock acquisition rights: 3,022”; “Common shares: 302,200”; “Exercise period for stock acquisition rights: 1 July 2023 to 30 June 2024”; “Number of stock acquisition rights: 471”; “Common shares: 47,100”」
The 9th and 10th Series Stock Acquisition Rights were issued, covering a total of 349,300 shares, with an exercise period from July 2023 to June 2024 and performance conditions including ordinary profit exceeding ¥12.5 billion for the fiscal year ending March 2023. - FY2020RestatedAnnual report
「The 7th Series Stock Acquisition Rights cover 234,400 shares and the 8th Series Stock Acquisition Rights cover 18,600 shares, for a total of 253,000 shares. If all are exercised, the total number of the Company's common shares issued will increase by an amount equivalent to 1.14% of the total number of shares issued.」
The full-year notes confirm that the 7th and 8th Series Stock Acquisition Rights cover 253,000 shares, equivalent to 1.14% of the total number of shares issued, with an exercise period from July 2023 to June 2024. - FY2020-Q2AdvancedAnnual report
「To further increase the motivation and morale of the Company's employees and the directors and employees of its subsidiaries, and to strengthen their unity, with the aim of achieving medium- to long-term growth in the Group's business performance and corporate value, the Company will issue the 7th Series Stock Acquisition Rights for consideration and the 8th Series Stock Acquisition Rights free of charge. The 7th Series Stock Acquisition Rights cover 234,400 shares and the 8th Series Stock Acquisition Rights cover 18,600 shares, for a total of 253,000 shares. If all are exercised, the total number of the Company's common shares issued will increase by an amount equivalent to 1.14% of the total number of shares issued.」
The Company resolved to issue the 7th and 8th Series Stock Acquisition Rights, specifying 253,000 underlying shares, equivalent to 1.14% of the total number of shares issued. Exercise conditions, periods and prices were set at the same levels as for the 5th and 6th Series. - FY2019RestatedAnnual report
「5th Series Stock Acquisition Rights: Common shares, 1,270,000; 6th Series Stock Acquisition Rights: Common shares, 105,000; Exercise period: 1 July 2023 to 30 June 2024」
The full-year notes confirm the number of shares granted, service period, exercise period and performance conditions for the 5th and 6th Series Stock Acquisition Rights. - FY2019-Q2AdvancedAnnual report
「During the second quarter of the current consolidated fiscal period, the Company issued stock acquisition rights. “Number of stock acquisition rights: 12,700”; “Common shares: 1,270,000”; “Exercise period for stock acquisition rights: 1 July 2023 to 30 June 2024”; “Number of stock acquisition rights: 1,050”; “Common shares: 105,000”」
The 5th and 6th Series Stock Acquisition Rights were issued, specifying the number of underlying shares and the exercise period from July 2023 to June 2024. - FY2019-Q1First statedAnnual report
「To further increase the motivation and morale of the Company's directors and employees and the directors and employees of its subsidiaries, and to strengthen their unity, with the aim of achieving medium- to long-term growth in the Company's business performance and corporate value, the Company will issue the 5th Series Stock Acquisition Rights for consideration and the 6th Series Stock Acquisition Rights free of charge. The 5th Series Stock Acquisition Rights cover 1,500,000 shares and the 6th Series Stock Acquisition Rights cover 110,000 shares, for a total of 1,610,000 shares. If all are exercised, the total number of the Company's common shares issued will increase by an amount equivalent to 7.24% of the total number of shares issued.」
The Company granted stock acquisition rights for consideration and free of charge to directors, employees and others, with an exercise period from July 2023 to June 2024 and performance conditions, positioning them as incentives for medium- to long-term business growth and enhancement of corporate value.